Research programme: cannabis extract therapeutics - One World Cannabis

Drug Profile

Research programme: cannabis extract therapeutics - One World Cannabis

Alternative Names: Cannabidiol - One World Cannabis; Medical cannabis - One World Cannabis; Tethahydrocannabidiol - One World Cannabis

Latest Information Update: 10 May 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator One World Cannabis
  • Developer One World Cannabis; The Chaim Sheba Medical Center at Tel Hashomer
  • Class Cannabinoids; Small molecules
  • Mechanism of Action Cannabinoid receptor CB1 antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Fibromyalgia; Multiple myeloma
  • Research Migraine; Post-traumatic stress disorders

Most Recent Events

  • 03 May 2017 One World Cannabis plans a clinical trial for Multiple myeloma (Sublingual)
  • 30 Sep 2016 Cannabis extract therapeutics licensed to MedMar in USA
  • 29 Mar 2016 Early research in Migraine in Israel (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top